Unraveling the tumor microenvironment of esophageal squamous cell carcinoma through single-cell sequencing: A comprehensive review
Lingyu Qi,
No information about this author
Jiaxin Wang,
No information about this author
Shuang Hou
No information about this author
et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer,
Journal Year:
2025,
Volume and Issue:
unknown, P. 189264 - 189264
Published: Jan. 1, 2025
Language: Английский
Cancer-associated fibroblasts in hepatocellular carcinoma: heterogeneity, mechanisms and therapeutic targets
Hepatology International,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 20, 2025
Language: Английский
Cancer therapy resistance mediated by cancer-associated fibroblast-derived extracellular vesicles: biological mechanisms to clinical significance and implications
Molecular Cancer,
Journal Year:
2024,
Volume and Issue:
23(1)
Published: Sept. 7, 2024
Cancer-associated
fibroblasts
(CAFs)
are
a
diverse
stromal
cell
population
within
the
tumour
microenvironment,
where
they
play
fundamental
roles
in
cancer
progression
and
patient
prognosis.
Multiple
lines
of
evidence
have
identified
that
CAFs
critically
involved
shaping
structure
function
microenvironment
with
numerous
functions
regulating
behaviours,
such
as
metastasis,
invasion,
epithelial-mesenchymal
transition
(EMT).
can
interact
extensively
cells
by
producing
extracellular
vesicles
(EVs),
multiple
secreted
factors,
metabolites.
Notably,
CAF-derived
EVs
been
critical
mediators
therapy
resistance,
constitute
novel
targets
biomarkers
management.
This
review
aimed
to
summarize
biological
detailed
molecular
mechanisms
mediating
resistance
chemotherapy,
targeted
agents,
radiotherapy,
immunotherapy.
We
also
discussed
therapeutic
potential
clinical
management,
thereby
providing
strategy
for
enhancing
efficacy
improving
Language: Английский
Targeting extracellular matrix interaction in gastrointestinal cancer: Immune modulation, metabolic reprogramming, and therapeutic strategies
Jiyifan Li,
No information about this author
Wenxin Zhang,
No information about this author
Lu Chen
No information about this author
et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer,
Journal Year:
2024,
Volume and Issue:
unknown, P. 189225 - 189225
Published: Nov. 1, 2024
Language: Английский
Cancer‑associated fibroblasts: a pivotal regulator of tumor microenvironment in the context of radiotherapy
Linhui Zheng,
No information about this author
Wenqi Cai,
No information about this author
Ke Yuan
No information about this author
et al.
Cell Communication and Signaling,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: March 20, 2025
In
the
course
of
tumor
treatment,
radiation
therapy
(RT)
not
only
kills
cancer
cells,
but
also
induces
complex
biological
effects
in
non-malignant
cells
around
cells.
These
such
as
angiogenesis,
changes
stromal
composition
and
immune
cell
infiltration
remodel
microenvironment
(TME).
As
one
major
components
TME,
Cancer‑associated
fibroblasts
(CAFs)
are
involved
tumorigenesis,
progression,
recurrence,
metastasis
regulate
tumor-associated
microenvironment.
CAFs
or
have
intercellular
communication
context
radiation.
Main
content.
Different
cellular
precursors,
spatial
location
differences,
absence
specific
markers,
advances
single-cell
sequencing
technology
gradually
made
abundant
heterogeneity
well
known.
Due
to
unique
radioresistance
properties,
can
survive
under
high
doses
ionizing
However,
induce
phenotypic
functional
further
act
on
promote
inhibit
progression.
To
date,
effect
RT
irradiated
progression
TME
still
defined.
this
review,
we
review
origin,
phenotypic,
describe
CAFs,
focusing
mutual
crosstalk
between
after
We
discuss
emerging
strategies
for
targeted
therapy.
Language: Английский
Association of SIRT6 Expression With Risk of Pneumonitis Induced by Radiotherapy in Cancer Patients
Fengyuan Yu,
No information about this author
Zheng Gong,
No information about this author
Yuan Li
No information about this author
et al.
Molecular Carcinogenesis,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 1, 2025
Thoracic
tumours
represent
a
significant
proportion
of
malignant
cancers.
While
radiotherapy
(RT)
improves
prognosis,
it
can
also
lead
to
side
effects
such
as
radiation-induced
pneumonitis
(RP).
Since
SIRT6
is
involved
in
DNA
repair,
energy
metabolism
and
inflammation,
this
study
aims
investigate
the
expression
lymphocytes
potential
biomarker
therapeutic
target
for
RP.
This
included
170
patients
diagnosed
with
thoracic
tumours,
all
whom
underwent
RT.
RP
was
evaluated
classified
severe
(SRP)
lower
non-severe
(NSRP).
Analyses
were
performed
using
SPSS
version
26.0
R.
Among
study,
124
developed
NSRP,
46
experienced
SRP.
The
univariate
analysis
showed
that
(cOR,
0.33,
95%CI,
0.18-0.97
before
RT
0.31,
0.19-0.98
after
RT),
clinical
factors,
dosimetric
parameters
haematological/serological
associated
SRP
Our
multivariable
logistic
regression
significantly
risk
(aOR,
0.32,
0.15-0.96)
0.18-0.99)
adjustment
other
confounders.
Moreover,
receiver
operating
characteristic
curve
revealed
combined
model
exhibited
superior
predictive
capability
compared
any
single
predictor
(overall
AUC,
0.93,
0.90-0.97
0.91,
0.87-0.96
RT).
alone
or
combination
factors
an
increased
SRP,
suggesting
novel
approach
prevention
treatment
radiation
practice.
Language: Английский